[1] Solez K et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411–422
[2] Hofer J et al. Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d. FASEB J 2016; 30:1492–503
[3] Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3:665–673
[4] Racusen LC et al. Antibody-mediated rejection criteria – an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 2003; 3:708–714
[5] Feucht HE. Complement C4d in graft capillaries – the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3:646–652
[6] Kikic ZAK et al. Capillary C4d and kidney allograft outcome in relation to morphological lesions suggestive of antibody-mediated rejection. Clin J Am Soc Nephrol 2015; 88:332–340
[7] Cohen D et al. Pros and cons for C4d as a biomarker. Kidney Int 2012; 81:628–639
[8] Haas M et al. Banff 2013 meeting report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 2014; 14:272–283
[9] Rose ML et al. Accommodation: does it apply to human leukocyte antigens? Transplantation 2012; 93:244–246
[10] Böhmig GA et al. Detection of alloantibody-mediated complement deposition: a diagnostic advance in monitoring kidney transplant rejection? Clin Biochem 2016; 49:394–403